Australian Consumer Finance Stock News

Catalyst Metals (ASX:CYL) has drawn fresh attention after announcing the departure of CFO Elena O'Connor, a leadership change that puts the spotlight on its financial oversight and upcoming executive transition plans. See our latest analysis for Catalyst Metals. Despite the recent CFO change and a softer patch that has seen a 1 month share price return of 7.98 percent and a 3 month share price return of 17.98 percent, the latest share price of A$6.34 still sits on the back of a powerful year...

On 2 December 2025, 4DMedical announced a significant expansion of its distribution agreement with Koninklijke Philips for CT:VQ, the company’s FDA-cleared, non-contrast CT ventilation and perfusion imaging solution. This deeper alignment with a global imaging leader could accelerate CT:VQ’s clinical adoption by pairing 4DMedical’s technology with Philips’ established hospital footprint and sales channels. We’ll now examine how the expanded Philips distribution for CT:VQ reshapes 4DMedical’s...

Key Insights Ansell's estimated fair value is AU$55.37 based on 2 Stage Free Cash Flow to Equity Ansell's AU$36.40...

Australian shares are poised for further gains this week, buoyed by a surge in copper prices, with the ASX futures indicating an upward trend. While penny stocks might seem like a throwback to earlier trading days, they remain relevant for investors seeking opportunities beyond the well-known giants. These smaller or newer companies can offer surprising value when backed by solid financial foundations, and we've identified three such stocks on the ASX that combine balance sheet strength with...

Investors may wish to note that the Executive Director of Prime Financial Group Limited , Matthew Murphy, recently...

Provaris Energy Ltd ( ASX:PV1 ) is possibly approaching a major achievement in its business, so we would like to shine...

Last week, Rapid Critical Metals Limited ( ASX:RCM ) insiders, who had purchased shares in the previous 12 months were...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Insiders who bought Atomo Diagnostics Limited ( ASX:AT1 ) stock in the last 12 months were richly rewarded last week...

Zoono Group Limited ( ASX:ZNO ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Last week, TerraCom Limited ( ASX:TER ) insiders, who had purchased shares in the previous 12 months were rewarded...

Macquarie Technology Group's (ASX:MAQ) stock is up by a considerable 11% over the past three months. Since the market...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Life360, Inc. ( ASX:360 ), is not the largest company out there, but it saw significant share price movement during...

Life360, Inc. ( ASX:360 ) shares have had a horrible month, losing 27% after a relatively good period beforehand...

COSOL Limited ( ASX:COS ) shareholders should be happy to see the share price up 22% in the last week. But that is...

Ampol Limited's ( ASX:ALD ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a strong buy right now...

Bellevue Gold (ASX:BGL) has confirmed it is back on track at Deacon North, resuming development and keeping first ore from this high grade zone pencilled in for the June 2026 quarter. See our latest analysis for Bellevue Gold. Investors seem to be leaning into that higher grade outlook, with the share price at A$1.425 driving a 22.84 percent 1 month share price return and a 62.86 percent 3 month share price return. The 3 year total shareholder return of 33.8 percent shows momentum has been...

APA Group (ASX:APA) has drawn fresh attention after signing a joint development agreement with CS Energy to lead and own 80% of the proposed 400MW Brigalow Peaking Power Plant in Queensland. See our latest analysis for APA Group. The Brigalow announcement lands after a busy stretch for APA, including the sale of its Networks business. It comes with the share price at A$9.29 after a robust year to date share price return of 32.34 percent and a strong 1 year total shareholder return of 40.33...

Telix Pharmaceuticals (ASX:TLX) just released ZIRCON-X study data showing its TLX250-CDx kidney imaging agent could have changed clinical decisions for almost half of patients, with more than 20% potentially avoiding invasive biopsy. See our latest analysis for Telix Pharmaceuticals. Despite the latest ZIRCON-X update highlighting the potential commercial impact of TLX250-CDx, Telix’s recent share price performance has been choppy, with a 1 month share price return of minus 9.68 percent and a...

When you see that almost half of the companies in the Telecom industry in Australia have price-to-sales ratios (or...

Some Mayfield Group Holdings Limited ( ASX:MYG ) shareholders may be a little concerned to see that the Non-Executive...

Insiders who bought XPON Technologies Group Limited ( ASX:XPN ) stock lover the last 12 months are probably not as...

Brookside Energy Limited ( ASX:BRK ) shares have continued their recent momentum with a 29% gain in the last month...